Results 201 to 210 of about 548,774 (332)

A Unique Case of Leukocyte Chemotactic Factor 2 Pulmonary Amyloidosis Causing Acute Respiratory Distress Syndrome [PDF]

, 2020
Arpana Paruchuri, Agner Paner, Priya Rajakumar, Mona Vashi   +3 more
openalex   +1 more source

Challenges and Opportunities in State‐of‐the‐Art Proteomics Analysis for Biomarker Development From Plasma Extracellular Vesicles

PROTEOMICS, EarlyView.
ABSTRACT Extracellular vesicles (EVs) are membrane‐bound particles secreted by cells, playing crucial roles in intercellular communication. The composition of EVs can undergo changes in response to stress and disease conditions, making them excellent biomarker candidates.
Panshak P. Dakup, Ivo Diaz Ludovico, Youngki You, Chaitra Rao, Javier Flores, Lisa M. Bramer, Marian Rewers, Bobbie‐Jo M. Webb‐Robertson, Thomas O. Metz, Raghavendra G. Mirmira, Emily K. Sims, Ernesto S. Nakayasu   +11 more
wiley   +1 more source

The Impact of Chronic Kidney Disease on In-Hospital Outcomes in Patients With Acute Respiratory Distress Syndrome. [PDF]

Can Respir J
Rao A, Anwar A, Agrawal A, Kichloo A, Singh J, Karki A.   +5 more
europepmc   +1 more source

Cannabidiol (CBD) modulation of apelin in acute respiratory distress syndrome [PDF]

, 2020
Évila Lopes Salles, Hesam Khodadadi, Abbas Jarrahi, Meenakshi Ahluwalia, Valdemar A. Paffaro, Vincenzo Costigliola, Jack C. Yu, David C. Hess, Krishnan M. Dhandapani, Babak Baban   +9 more
openalex   +1 more source

Rehabilitation needs of long COVID patients in British Columbia

PM&R, EarlyView.
Abstract Introduction COVID‐19 can result in persistent symptoms and functional impairment that significantly impact daily functioning, highlighting the need for targeted rehabilitation. However, there is a lack of data on what proportion of long COVID patients need rehabilitation and which types are required.
Débora M. Petry Moecke, Evan H. Kwong, Sonya Cressman, Jennifer Yao, Chiara Singh, Carolyn Taylor, Pat G. Camp   +6 more
wiley   +1 more source

Disease–Drug–Drug Interaction of Imatinib in COVID‐19 ARDS: A Pooled Population Pharmacokinetic Analysis

CPT: Pharmacometrics &Systems Pharmacology, Volume 14, Issue 3, Page 583-595, March 2025.
ABSTRACT Prior pharmacokinetic (PK) analysis revealed that increased alpha‐1‐acid glycoprotein (AAG) levels are associated with decreased imatinib unbound fraction in coronavirus disease 2019 (COVID‐19) patients. This study aimed to investigate the PK of total and unbound concentrations of imatinib and the metabolite N‐desmethyl imatinib in ...
Medhat M. Said, Job R. Schippers, Leila Atmowihardjo, Yingxue Li, Mick S. van der Plas, Harm J. Bogaard, Lieuwe D. J. Bos, Ron A. A. Mathôt, Jurjan Aman, Eleonora L. Swart, Imke H. Bartelink   +10 more
wiley   +1 more source

Exploring Transient Acute Respiratory Distress in Cholera: A Case Series. [PDF]

Clin Case Rep
Amo-Tachie S.
europepmc   +1 more source

IL-35 interferes with splenic T cells in a clinical and experimental model of acute respiratory distress syndrome

, 2018
Chuanjiang Wang, Mu Zhang, Hua Wu, Shihui Lin, Fang Xu   +4 more
openalex   +2 more sources

A Novel Method Using Dual‐Energy Computed Tomography for Detecting Amiodarone‐Induced Lung Injury: A Cohort Pilot Study

Respirology, EarlyView.
There is no gold standard for detecting amiodarone‐induced‐lung injury (AILD). Dual‐Energy‐Computed‐Tomography (DECT) depicts iodine deposition in lungs abnormalities and the liver. We found a substantial correlation between the DECT assessment of AILD and comprehensive clinical evaluation of AILD. DECT can assist in the diagnosis of AILD.
Naama R. Bogot, Ariel Rokach, Irith Hadas‐Halperen, Yehonatan Cohen, Ayal Romem, Moshe Rav‐Acha, Tal Hasin, Gabriel Izbicki, Nissim Arish   +8 more
wiley   +1 more source

Trends and racial disparities in mortality related to acute respiratory distress syndrome. [PDF]

Proc (Bayl Univ Med Cent)
Furtado N, Ball S, Billion T, Mirza M.
europepmc   +1 more source